Uncategorized
Ethereum Rallies 42% In 7 Days: What Is Driving The Surge?
Ethereum (CRYPTO: ETH) has surged 42% over the past seven days, driven by the announcement of the Pectra upgrade, a pivotal step in Ethereum’s network evolution, and heavy institutional accumulation. read more
Only Half Of S&P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards?
Only about 50% of S&P 500 stocks trade above their 200-day average, signaling narrow breadth even as the index rallies 22% since April. read more
Alibaba’s 55% Rally Gets Goldman’s $1 Billion Boost – Will Q4 Earnings Justify The Bet?
Alibaba (BABA) will report Q4 earnings on Thursday. Wall Street expects $1.37 EPS and $33.21B revenue. Stock is up 54.9% YTD with bullish momentum. read more
Red Cat Holdings Stock Is Ripping Higher Wednesday: What’s Going On?
Red Cat Holdings Inc (NASDAQ:RCAT) shares are surging Wednesday after the company announced an expansion of its multi-domain Family of Systems to maritime platforms. Red Cat is due to report earnings after the bell. Here’s what you need to know. read more
FirstCash Enters UK Market With $394 Million Acquisition Of H&T Group
FirstCash Holdings Inc. expands into U.K. by acquiring H&T Group plc, largest pawnbroker chain. Deal worth $394 million adds 285 stores and boosts global presence. read more
Palantir Storms Past $300 Billion Valuation, CEO Karp Champions Saudi AI Over Europe
Palantir Technologies Inc (NASDAQ:PLTR) hits $300B market cap, up from $20B in 2 years. CEO praises Saudi engineers, criticizes Europe’s AI adoption. read more
The Curious Story Behind The Melania Trump Meme Coin Launch
The launch of the Melania (CRYPTO: MELANIA) meme coin, tied to former First Lady Melania Trump, has stirred controversy following a series of unusually timed trades that suggest some investors had early access read more
Expert Outlook: AbbVie Through The Eyes Of 10 Analysts
Latest Ratings for ABBV Date Firm Action From To Feb 2022 UBS Downgrades Buy Neutral Feb 2022 Mizuho Maintains Buy Feb 2022 Barclays Maintains Equal-Weight View More Analyst Ratings for ABBV View the Latest Analyst Ratings read more
Assessing Merck & Co: Insights From 4 Financial Analysts
Latest Ratings for MRK Date Firm Action From To Feb 2022 SVB Leerink Maintains Outperform Jan 2022 JP Morgan Maintains Overweight Dec 2021 Daiwa Capital Initiates Coverage On Neutral View More Analyst Ratings for MRK View the Latest Analyst Ratings read more